Benrixate

This classification denotes an antiarrhythmic agent with the molecular formula C19H30N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 58NL35I27K, chemically known as 4-benzyl-1-piperidinecarboxylic acid, 2-(diethylamino)ethyl ester but more generally known as benrixate, which bears US NIH Compound Identifier 184848. European Medicines Agency schedules Benrixate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05729MIG. The term BENRIXATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 27, No. 10 1973, List 13). BENRIXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule benrixate under HS 29333999 and SITC 51574. As of Q4 2014, BENRIXATE remains US FDA's Preferred Term for this commodity. Benrixate bears US NLM identifiers UMLS ID C2346995 and NCI Concept Code C74126. SMILES: O(C(=O)N1CCC(CC1)CC1CCCCC1)CCN(CC)CC.